Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)
Close on Nov 17, 2026Market cap $800.28MP/E –Yield –
Beta Bionics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Beta Bionics's operating cash flow for the twelve months ending Sep 30, 2026 was -$59.37M. For fiscal 2025 it was -$50.93M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$50.93M | – |
| FY2024 | Dec 31, 2024 | -$48.27M | – |
| FY2023 | Dec 31, 2023 | -$32.45M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$12.29M | – |
| Q2 FY2026 | Jun 30, 2026 | -$14.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.83M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.73M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.59M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.61M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.24M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.14M | – |
See a number that looks wrong?